ASSET | DATE | % RETURN |
---|---|---|
Andretti Acquisition Corp II Class A Ordinary Shares (POLE) | 10/29/2014 - 3/6/2015 | 896.73% |
CorMedix (CRMD) | 10/29/2014 - 3/6/2015 | 343.57% |
TSS, Inc Common Stock (TSSI) | 10/29/2014 - 3/6/2015 | 192% |
Ocular Therapeutix (OCUL) | 10/29/2014 - 3/6/2015 | 177.12% |
LifeMD (LFMD) | 10/29/2014 - 3/6/2015 | 171.43% |
Kimball Electronics (KE) | 10/29/2014 - 3/6/2015 | 135.26% |
Precigen (PGEN) | 10/29/2014 - 3/6/2015 | 133.3% |
Nutex Health (NUTX) | 10/29/2014 - 3/6/2015 | 128.57% |
Uniqure (QURE) | 10/29/2014 - 3/6/2015 | 123.82% |
ANI Pharmaceuticals (ANIP) | 10/29/2014 - 3/6/2015 | 120.71% |
Atlanticus (ATLC) | 10/29/2014 - 3/6/2015 | 113.18% |
Capricor Therapeutics (CAPR) | 10/29/2014 - 3/6/2015 | 102.13% |
Arcturus Therapeutics (ARCT) | 10/29/2014 - 3/6/2015 | 98.03% |
Iradimed (IRMD) | 10/29/2014 - 3/6/2015 | 95.93% |
Amarin (AMRN) | 10/29/2014 - 3/6/2015 | 95.6% |
Frp Holdings Ord (FRPH) | 10/29/2014 - 3/6/2015 | 91.86% |
Rigel Pharmaceuticals (RIGL) | 10/29/2014 - 3/6/2015 | 91.4% |
Semler Scientific (SMLR) | 10/29/2014 - 3/6/2015 | 88.03% |
Ingles Markets (IMKTA) | 10/29/2014 - 3/6/2015 | 86.2% |
Heron Therapeuti (HRTX) | 10/29/2014 - 3/6/2015 | 79.78% |
ODP (ODP) | 10/29/2014 - 3/6/2015 | 76.81% |
Celldex Therapeutics (CLDX) | 10/29/2014 - 3/6/2015 | 73.49% |
Allient (ALNT) | 10/29/2014 - 3/6/2015 | 71.85% |
SIGA Technologies (SIGA) | 10/29/2014 - 3/6/2015 | 71.42% |
Fubotv (FUBO) | 10/29/2014 - 3/6/2015 | 70.59% |